Advanced Accelerator Applications SA is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer. The Company has a portfolio of nine diagnostic positron emission tomography (PET) and single-photon emission computed tomography (SPECT) products.
Read More…
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone33-04-50-99-30-70
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$121.01 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Advanced Accelerator Application (NASDAQ:AAAP) Frequently Asked Questions
What is Advanced Accelerator Application's stock symbol?
Advanced Accelerator Application trades on the NASDAQ under the ticker symbol "AAAP."
How were Advanced Accelerator Application's earnings last quarter?
Advanced Accelerator Application SA (NASDAQ:AAAP) issued its quarterly earnings results on Thursday, August, 31st. The company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by $0.01. The business earned $40.14 million during the quarter, compared to analysts' expectations of $36.74 million. View Advanced Accelerator Application's Earnings History.
Has Advanced Accelerator Application been receiving favorable news coverage?
Media headlines about AAAP stock have been trending negative on Monday, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Advanced Accelerator Application earned a news sentiment score of -2.8 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Advanced Accelerator Application.
Who are some of Advanced Accelerator Application's key competitors?
Some companies that are related to Advanced Accelerator Application include Aeolus Pharmaceuticals (AOLS), Affymax (AFFY), American Oriental Bioengineering (AOBI), Aoxing Pharmaceutical (AOXG), Bohai Pharmaceuticals Group (BOPH), Concordia International (CXRX), Egalet (EGLT), Eleven Biotherapeutics (EBIO), Epirus Biopharmaceuticals (EPRSQ), ERBA Diagnostics (ERBA), FutureWorld (FWDG), GlobeImmune (GBIM), Mereo BioPharma Group (MREO), Myrexis (MYRX) and Orexigen Therapeutics (OREX).
What other stocks do shareholders of Advanced Accelerator Application own?
Who are Advanced Accelerator Application's key executives?
Advanced Accelerator Application's management team includes the folowing people:
- Susanne Schaffert, Chairman of the Board
- Stefano Buono, Chief Executive Officer (Age 52)
- Heinz Mausli, Chief Financial Officer (Age 52)
- Gerard Ber, Chief Operating Officer (Age 57)
- Claude A. Hariton Ph.D., Head of Clinical Development (Age 59)
- Maurizio Franco Mariani, Global Head of Pre-Clinical Research (Age 55)
- Frederic Collet, Director
- Augusto Lima, Director
- Jessica Toepfer, Director
- Kapil Dhingra, Independent Director (Age 58)
When did Advanced Accelerator Application IPO?
(AAAP) raised $76 million in an initial public offering (IPO) on Thursday, February 5th 2015. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. Citigroup and Jefferies acted as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.
What is Advanced Accelerator Application's official website?
How can I contact Advanced Accelerator Application?
Advanced Accelerator Application's mailing address is 20 Rue Diesel, Saint Genis Pouilly I0, 01630. The company can be reached via phone at 33-04-50-99-30-70 or via email at [email protected]
MarketBeat Community Rating for Advanced Accelerator Application (NASDAQ AAAP)
MarketBeat's community ratings are surveys of what our community members think about Advanced Accelerator Application and other stocks. Vote "Outperform" if you believe AAAP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AAAP will underperform the S&P 500 over the long term. You may vote once every thirty days.
